Skip to main content
Clinical Trials/NCT05216861
NCT05216861
Recruiting
N/A

Evaluation of a Collaborative Intervention to Promote Early Employer Contact and Return to Work Among People With Common Mental Disorders or Long-term Pain

Uppsala University1 site in 1 country120 target enrollmentFebruary 15, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pain, Chronic
Sponsor
Uppsala University
Enrollment
120
Locations
1
Primary Endpoint
Sick leave
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The overall aim of this cluster ranomized controlled trial is to investigate whether an intervention for collaboration between patient with CMD or chronic pain and employer (the Demand and Ability Protocol) can contribute to reduced sick leave and to increased health, work ability and trust in the managers. The intervention is delivered by rehabiliation coordinators at primary health care centres.

Detailed Description

The overall aim of this cluster ranomized controlled trial is to investigate whether an intervention for collaboration between patient with CMD or chronic pain and employer (the Demand and Ability Protocol) can contribute to reduced sick leave and to increased health, work ability and trust in the managers. The intervention is delivered by rehabilitation coordinators at primary health care centres. Furthermore, the aim is to identify hindering and facilitating factors for feasibility, usability and implementation of the Demand and Ability Protocol intervention (DAP) in primary health care. Research questions: 1. What is the effect of DAP for patients regarding sick leave, health, work ability, and trust in the manager compared to matched controls who do not recieve DAP? 2. How do patients and managers experience their participation in the intervention and how do they experience the usability of the DAP? 3. What facilitating and hindering factors exist for the introduction and implementation of DAP in primary health care, and how do rehabilitation coordinators (REKO) and medical doctors experience the feasibility and usability of the intervention?

Registry
clinicaltrials.gov
Start Date
February 15, 2022
End Date
December 21, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Uppsala University
Responsible Party
Principal Investigator
Principal Investigator

Therese Hellman

PhD, Associate professor

Uppsala University

Eligibility Criteria

Inclusion Criteria

  • have a diagnosis of CMD and/or chronic pain
  • have a job
  • be on full-time or part time sick leave
  • accept the manager's involvement.

Exclusion Criteria

  • been on full-time sick leave for more than 6 months before the first contact with REKO

Outcomes

Primary Outcomes

Sick leave

Time Frame: From baseline until 12 months

The total number of days on sick leave due to CMDs or chronic pain during the 12 month follow-up period

Study Sites (1)

Loading locations...

Similar Trials